Page last updated: 2024-10-21

meglutol and Cancer of Gastrointestinal Tract

meglutol has been researched along with Cancer of Gastrointestinal Tract in 1 studies

Meglutol: An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate limiting enzyme in the biosynthesis of cholesterol.
3-hydroxy-3-methylglutaric acid : A dicarboxylic acid that is glutaric acid in which one of the two hydrogens at position 3 is substituted by a hydroxy group, while the other is substituted by a methyl group. It has been found to accumulate in urine of patients suffering from HMG-CoA lyase (3-hydroxy-3-methylglutaryl-CoA lyase, EC 4.1.3.4) deficiency. It occurs as a plant metabolite in Crotalaria dura.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tabacik, C1
Aliau, S1
Astruc, M1
De Paulet, AC1

Other Studies

1 other study available for meglutol and Cancer of Gastrointestinal Tract

ArticleYear
Squalene epoxidase, oxido-squalene cyclase and cholesterol biosynthesis in normal and tumoral mucosa of the human gastro-intestinal tract. Evidence of post-HHG CoA regulation.
    Biochimica et biophysica acta, 1981, Dec-23, Volume: 666, Issue:3

    Topics: Acetates; Acetic Acid; Adult; Aged; Animals; Cholesterol; Female; Gastric Mucosa; Gastrointestinal N

1981